Form 4 holding
Director
Anika Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 258,788
- Estimated value
- $2,486,952
- Report date
- 15 Mar 2026
- Price
- $9.61
- Ownership
- Direct
Cheryl R. Blanchard - Director at Anika Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- ANIK on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Cheryl R. Blanchard since 09 Aug 2025
Reported holdings for Cheryl R. Blanchard in Anika Therapeutics, Inc.
Form 4 holding
Director
Anika Therapeutics, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 25,132
- Estimated value
- $799,684
- Report date
- 15 Mar 2026
- Price
- $15.91
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Anika Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 11,742
- Estimated value
- $112,840
- Report date
- 14 Mar 2026
- Price
- $9.61
- Ownership
- Revocable Trust
Transaction history for Cheryl R. Blanchard in Anika Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.